Market Cap : 322.08 M | Enterprise Value : 289.7 M | P/E (TTM) : 435.25 | P/B : 7.23 |
---|
NAS:BLFS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BLFS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
vs
industry |
vs
history |
||
---|---|---|---|
Cash-to-Debt | No Debt |
100% of the 205 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.74 vs. NAS:BLFS: No Debt ) Ranked among companies with meaningful Cash-to-Debt only. |
NAS:BLFS'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: No Debt Max: No Debt Current: No Debt |
Equity-to-Asset | 0.95 |
80% of the 196 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 0.60 vs. NAS:BLFS: 0.95 ) Ranked among companies with meaningful Equity-to-Asset only. |
NAS:BLFS'
s Equity-to-Asset Range Over the Past 10 Years
Min: -7.3 Med: 0.51 Max: 0.95 Current: 0.95 |
Piotroski F-Score: 8 |
|
Altman Z-Score: 70.47 |
|
Beneish M-Score: -1.49 |
|
WACC vs ROIC |
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
vs
industry |
vs
history |
||
---|---|---|---|
Operating Margin % | 13.79 |
73% of the 201 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.41 vs. NAS:BLFS: 13.79 ) Ranked among companies with meaningful Operating Margin % only. |
NAS:BLFS'
s Operating Margin % Range Over the Past 10 Years
Min: -186.31 Med: -54.82 Max: 13.79 Current: 13.79 |
Net Margin % | 10.42 |
83% of the 201 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.18 vs. NAS:BLFS: 10.42 ) Ranked among companies with meaningful Net Margin % only. |
NAS:BLFS'
s Net Margin % Range Over the Past 10 Years
Min: -209.91 Med: -68.14 Max: 10.42 Current: 10.42 |
ROE % | 7.83 |
91% of the 198 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 5.43 vs. NAS:BLFS: 7.83 ) Ranked among companies with meaningful ROE % only. |
NAS:BLFS'
s ROE % Range Over the Past 10 Years
Min: -117.78 Med: -41.49 Max: 7.83 Current: 7.83 |
ROA % | 8.94 |
89% of the 206 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.85 vs. NAS:BLFS: 8.94 ) Ranked among companies with meaningful ROA % only. |
NAS:BLFS'
s ROA % Range Over the Past 10 Years
Min: -292.57 Med: -68.23 Max: 8.94 Current: 8.94 |
ROC (Joel Greenblatt) % | 44.96 |
81% of the 204 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 9.63 vs. NAS:BLFS: 44.96 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
NAS:BLFS'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1601.29 Med: -162.79 Max: 44.96 Current: 44.96 |
3-Year Revenue Growth Rate | 11.90 |
92% of the 170 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.10 vs. NAS:BLFS: 11.90 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
NAS:BLFS'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -49.5 Med: 2.95 Max: 416.2 Current: 11.9 |
3-Year EBITDA Growth Rate | 18.20 |
99% of the 155 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 10.00 vs. NAS:BLFS: 18.20 ) Ranked among companies with meaningful 3-Year EBITDA Growth Rate only. |
NAS:BLFS'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -215.9 Med: 7.5 Max: 58.5 Current: 18.2 |
3-Year EPS without NRI Growth Rate | 12.20 |
92% of the 155 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 12.90 vs. NAS:BLFS: 12.20 ) Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only. |
NAS:BLFS'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0 Med: 8.15 Max: 48.9 Current: 12.2 |
First Eagle Investment 177,578 sh (New) Jim Simons 443,500 sh (+3.65%) |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
Guru | Date | Action |
Impact | Price Range (Average)* |
Change from Average | Comment | Current Shares |
---|
Industry: | Medical Instruments & Equipment » Medical Instruments & Supplies NAICS: 339113 SIC: 3841 | |
---|---|---|
Compare: | NAS:ATEC, OSTO:SEDANA, OTCPK:NTRB, HKSE:01120, XKRX:104540, ISX:MARK, NAS:LAKE, NAS:EKSO, BKK:TOG, AMEX:BVX, NAS:CFMS, OSTO:BONEX, XMCE:BIO, ASX:GMV, XKRX:241820, ASX:CLV, AMEX:INFU, XPAR:BUP, OTCPK:BFNH, ROCO:4729 » details | |
Traded in other countries: | BJX1.Germany, | |
Headquarter Location: | USA |
vs
industry |
vs
history |
||
---|---|---|---|
PE Ratio | 435.25 |
99.99% of the 125 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 31.70 vs. BLFS: 435.25 ) Ranked among companies with meaningful PE Ratio only. |
BLFS'
s PE Ratio Range Over the Past 10 Years
Min: 237.5 Med: 317 Max: 529.75 Current: 435.25 |
Forward PE Ratio | 59.88 |
100% of the 40 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 26.32 vs. BLFS: 59.88 ) Ranked among companies with meaningful Forward PE Ratio only. |
N/A |
PE Ratio without NRI | 435.25 |
99.99% of the 123 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 9999.00 vs. BLFS: 435.25 ) Ranked among companies with meaningful PE Ratio without NRI only. |
BLFS'
s PE Ratio without NRI Range Over the Past 10 Years
Min: 237.5 Med: 317 Max: 529.75 Current: 435.25 |
PB Ratio | 7.24 |
90% of the 193 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.45 vs. BLFS: 7.24 ) Ranked among companies with meaningful PB Ratio only. |
BLFS'
s PB Ratio Range Over the Past 10 Years
Min: 1.68 Med: 3.53 Max: 20.89 Current: 7.24 |
PS Ratio | 17.81 |
78% of the 192 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.48 vs. BLFS: 17.81 ) Ranked among companies with meaningful PS Ratio only. |
BLFS'
s PS Ratio Range Over the Past 10 Years
Min: 0.76 Med: 3.31 Max: 26.08 Current: 17.81 |
Price-to-Free-Cash-Flow | 134.97 |
99.99% of the 74 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 28.61 vs. BLFS: 134.97 ) Ranked among companies with meaningful Price-to-Free-Cash-Flow only. |
BLFS'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 69.32 Med: 134.5 Max: 3500 Current: 134.97 |
Price-to-Operating-Cash-Flow | 117.64 |
99.99% of the 94 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 21.15 vs. BLFS: 117.64 ) Ranked among companies with meaningful Price-to-Operating-Cash-Flow only. |
BLFS'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.38 Med: 88.22 Max: 372.34 Current: 117.64 |
EV-to-EBIT | 174.09 |
99.99% of the 121 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 23.93 vs. BLFS: 174.09 ) Ranked among companies with meaningful EV-to-EBIT only. |
BLFS'
s EV-to-EBIT Range Over the Past 10 Years
Min: -237.3 Med: -5.1 Max: 4429.5 Current: 174.09 |
EV-to-EBITDA | 145.72 |
99.99% of the 138 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 19.49 vs. BLFS: 145.72 ) Ranked among companies with meaningful EV-to-EBITDA only. |
BLFS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -700.6 Med: -5.4 Max: 1152.9 Current: 145.72 |
EV-to-Revenue | 16.63 |
81% of the 199 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.57 vs. BLFS: 16.63 ) Ranked among companies with meaningful EV-to-Revenue only. |
BLFS'
s EV-to-Revenue Range Over the Past 10 Years
Min: -0.2 Med: 4 Max: 33.5 Current: 16.63 |
Current Ratio | 18.28 |
82% of the 200 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.57 vs. BLFS: 18.28 ) Ranked among companies with meaningful Current Ratio only. |
BLFS'
s Current Ratio Range Over the Past 10 Years
Min: 0.09 Med: 2.14 Max: 55 Current: 18.28 |
Quick Ratio | 16.89 |
79% of the 201 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.87 vs. BLFS: 16.89 ) Ranked among companies with meaningful Quick Ratio only. |
BLFS'
s Quick Ratio Range Over the Past 10 Years
Min: 0.04 Med: 1.47 Max: 55 Current: 16.89 |
Days Inventory | 133.11 |
68% of the 197 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 124.35 vs. BLFS: 133.11 ) Ranked among companies with meaningful Days Inventory only. |
BLFS'
s Days Inventory Range Over the Past 10 Years
Min: 37.89 Med: 138.59 Max: 193.93 Current: 133.11 |
Days Sales Outstanding | 56.55 |
73% of the 165 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 61.97 vs. BLFS: 56.55 ) Ranked among companies with meaningful Days Sales Outstanding only. |
BLFS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.81 Med: 53.08 Max: 77.03 Current: 56.55 |
Days Payable | 68.58 |
66% of the 151 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 54.66 vs. BLFS: 68.58 ) Ranked among companies with meaningful Days Payable only. |
BLFS'
s Days Payable Range Over the Past 10 Years
Min: 34.86 Med: 72.62 Max: 311.98 Current: 68.58 |
vs
industry |
vs
history |
||
---|---|---|---|
3-Year Average Share Buyback Ratio | -5.10 |
92% of the 143 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: -5.00 vs. BLFS: -5.10 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
BLFS'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -77.4 Med: -0.2 Max: 28.4 Current: -5.1 |
vs
industry |
vs
history |
||
---|---|---|---|
Price-to-Net-Cash | 10.62 |
88% of the 49 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 13.15 vs. BLFS: 10.62 ) Ranked among companies with meaningful Price-to-Net-Cash only. |
BLFS'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.4 Med: 4.6 Max: 63.44 Current: 10.62 |
Price-to-Net-Current-Asset-Value | 8.88 |
77% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 8.83 vs. BLFS: 8.88 ) Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only. |
BLFS'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.06 Med: 4.42 Max: 61.33 Current: 8.88 |
Price-to-Tangible-Book | 7.22 |
81% of the 167 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.77 vs. BLFS: 7.22 ) Ranked among companies with meaningful Price-to-Tangible-Book only. |
BLFS'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.97 Med: 4.63 Max: 49.35 Current: 7.22 |
Price-to-Intrinsic-Value-Projected-FCF | 31.09 | ||
Price-to-Median-PS-Value | 5.39 |
88% of the 160 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.13 vs. BLFS: 5.39 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
BLFS'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.38 Med: 0.92 Max: 11.13 Current: 5.39 |
Price-to-Graham-Number | 11.84 |
99.99% of the 94 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.77 vs. BLFS: 11.84 ) Ranked among companies with meaningful Price-to-Graham-Number only. |
BLFS'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 10.99 Med: 11.9 Max: 11.9 Current: 11.84 |
Earnings Yield (Greenblatt) % | 0.57 |
75% of the 207 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.40 vs. BLFS: 0.57 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
BLFS'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1126.4 Med: -17.7 Max: 2881.8 Current: 0.57 |
Revenue (TTM) (Mil) $ | 17.42 |
---|---|
EPS (TTM) $ | 0.04 |
Beta | 2.23 |
Volatility | 101.51% |
52-Week Range $ | 4.85 - 26.35 |
Shares Outstanding (Mil) | 18.50 |
Dec18 | Dec19 | Dec20 | Dec21 | |
---|---|---|---|---|
Revenue (Mil $) | 20 | 28 | 39 | 54 |
EBIT (Mil $) | ||||
EBITDA (Mil $) | ||||
EPS ($) | 0.15 | 0.27 | 0.48 | 0.78 |
EPS without NRI ($) | 0.15 | 0.27 | 0.48 | 0.78 |
EPS Growth Rate (Future 3Y To 5Y Estimate) | N/A | |||
Dividends per Share ($) |
|
GF Chat